Filing Details

Accession Number:
0001104659-17-025903
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-25 16:30:45
Reporting Period:
2016-09-16
Filing Date:
2017-04-25
Accepted Time:
2017-04-25 16:30:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660719 Aralez Pharmaceuticals Inc. ARLZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376960 Jason Aryeh C/O Aralez Pharmaceuticals Inc.,
7100 West Credit Avenue, Suite 101
Mississauga A6 L5N 0E4
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Acquisiton 2016-09-16 295,929 $5.86 343,216 No 4 P Indirect By JALAA Equities, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By JALAA Equities, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares, Without Par Value 7,500 Direct
Footnotes
  1. Securities are owned by JALAA Equities, LP, of which the Reporting Person is the general partner. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, the Reporting Person may be deemed to be the beneficial owner of the securities owned by JALAA Equities, LP.